Program and Proceedings - 5th Caribbean Biomedical Research Days CBRD-2018, Jan 16-18, 2018, Rodney Bay, St. Lucia

5th ISBS Caribbean Biomedical Research Days, January 16-18, 2018
CBRD-2018 St. Lucia, West Indies – www.stressandbehavior.com
The International Stress and Behavior Society (ISBS)
Program and
Proceedings
th
5 Caribbean Biomedical
Research Days CBRD-2018
Rodney Bay, St. Lucia

January 16-18, 2018
IN PARTNERSHIP WITH OUR OFFICIAL SPONSORS:

CONFERENCE PROGRAM:
DAY 1. Tuesday, January 16, 2018
Dolphins Conference Center, Bay Gardens Beach Resort & Spa, Rodney Bay, St. Lucia
09.30 – 10.00 Registration
10.00 – 10.20 CONFERENCE OPENING REMARKS. BRIEF INTRODUCTION TO THE

HISTORY OF ISBS AND CBRD. WELCOMING ADDRESSES
10.20 – 11.00 ISBS Lecture 1: PROTEIN KINASE C IN THE PATHOPHYSIOLOGY OF

BIPOLAR ILLNESS: A POTENTIAL BIOLOGICAL MARKER. GN
Pandey, ISBS Fellow, University of Illinois at Chicago, Department of
Psychiatry, Chicago, IL, USA
11.00 - 11.40 ISBS Lecture 2: CELL-TYPE SPECIFIC MECHANISMS OF GENE-

ENVIRONMENT INTERACTION IN PSYCHIATRIC DISORDERS. M
Pletnikov, ISBS Fellow, Johns Hopkins University School of Medicine,
Baltimore, MD, USA
11.40 - 12.10 THE EFFECTS OF MINDFULNESS-ORIENTED RECOVERY

ENHANCEMENT ON ALLOSTATIC MECHANISMS IN STRESS, PAIN,
AND ADDICTION. E Garland, University of Utah, Salt Lake City, UT, USA
12.10 – 12.40 ROUND TABLE: IMPROVING THE VALIDITY OF BIOMEDICAL

RESEARCH
12.40 – 02.00 Lunch Break (free time)
02.00 - 03.40 SYMPOSIUM 1. ZUKOWSKA SYMPOSIUM ON BIOLOGICAL

PSYCHIATRY. CHAIR: AV KALUEFF (USA)
02.00 - 02.10 INTRODUCTION: PROFESSOR ZOFIA ZUKOWSKA
02.10 - 02.35 THE IMPACT OF A BEHAVIORAL INTERVENTION ON FAMILY

CAREGIVERS’ C-REACTIVE PROTEIN. PR Sherwood, HS Donovan, L
Terhorst, A Marsland, BA Given and CW Given, University of Pittsburgh,
Pittsburgh, PA, USA
02.35 - 03.00 ASSOCIATION BETWEEN EARLY AND RECENT LIFE STRESS AND
DNA METHYLATION - EPIGENOME-WIDE ASSOCIATION STUDY. WL
Dragan, A Sokołowski, P Stawiński, P Gasperowicz, G Kostrzewa and R
Płoski, Interdisciplinary Centre for Behavioural Genetics Research, Faculty
of Psychology, University of Warsaw, Departments of Medical Genetics,
and Forensic Medicine, Medical University of Warsaw, Warsaw, Poland
03.00 - 03.25 DOES RUMINATION ALLOW TO PREDICT EMOTIONAL DISORDERS?

M Dragan, University of Warsaw, Warsaw, Poland
03.25 - 03.40 GENERAL DISCUSSION
03.40 – 04.00 Coffee Break
04.00 - 04.30 ISBS Special Focus talk: UNDERSTANDING ANTIDEPPRESSANT

DISCONTINUATION SYNDROME (ASD) – BRIDGING CLINICAL AND
PRECLINICAL FINDINGS. KN Zabegalov, TO Kolesnikova, SL Khatsko,
AD Volgin, OA Yakovlev, TG Amstislavskaya, PA Alekseeva, DA
Meshalkina, AJ Friend, W Bao, KA Demin and AV Kalueff, ISBS Fellow,
Ural Federal University, Yekaterinburg, Institute of Translational
Biomedicine, St. Petersburg State University, St. Petersburg, Laboratory of
Translational Biopsychiatry, Research Institute of Physiology and Basic
Medicine, Department of Neuroscience, Novosibirsk State University,
Novosibirsk, Russia; School of Pharmacy, Southwest University,
Chongqing, China; Institute of Experimental Medicine, Almazov National
Medical Research Center, St. Petersburg, Russia; Tulane University School
of Science and Engineering, New Orleans, The International Zebrafish
Neuroscience Research Consortium (ZNRC), ZENEREI Research Center,
Slidell, LA, USA
04.30 - 05.00 VIDEO-PRESENTATION: ART MEETS SCIENCE. D Raytchev, D

Raytchev Art, London, UK
DAY 2. Wednesday, January 17, 2018

09.00 – 09.30 Registration
09.30 – 10.10 ISBS Plenary Lecture 3: PAIN MANAGEMENT IN THE CANCER

PATIENT. WCV Parris, Department of Anesthesiology, Duke University
Medical Center, Durham, NC, USA
10.10 - 01.15 SYMPOSIUM 2. LAPIN SYMPOSIUM ON TRANSLATIONAL BIO-

MEDICINE. CHAIR: MV PLETNIKOV (USA)
10.10 – 10.20 INTRODUCTION: PROFESSOR IZYASLAV LAPIN
10.20 - 10.40 ISBS Presidential Lecture 4: ZEBRAFISH MODELS OF DRUG ABUSE

AND STRESS. AV Kalueff, ISBS Fellow, ZENEREI Research Center,
Slidell, LA, USA; Southwest University, Chongqing, China; St. Petersburg
State University, St. Petersburg, Ural Federal University, Ekaterinburg,
Russia
10.40 - 11.20 ISBS Plenary Lecture 5: HIV PREVENTION, TREATMENT AND CARE
AMONG PEOPLE WHO USE STIMULANT DRUGS AND THEIR SEXUAL
PARTNERS, AN IMPLEMENTATION GUIDE. M Day, ISBS Fellow,
Caribbean Drug and Alcohol Research Institute (CDARI), Castries, St.
Lucia
11.20 - 11.35 PREVALENCE OF ORAL HPV INFECTION AMONG HEALTHY

INDIVIDUALS AND HEAD AND NECK CANCER CASES IN THE
FRENCH WEST INDIES. A Auguste, S Gaete, C Herrmann-Storck, L
Michineau, C Joachim, J Deloumeaux, S Duflo and D Luce, INSERM U
1085- IRSET (Research Institute for Environmental and Occupational
Health), Pointe-à-Pitre, Guadeloupe, University of Rennes, Rennes, Centre
de Ressources Biologiques de Guadeloupe, Laboratory of Microbiology,
University Hospital of Guadeloupe, Pointe-à-Pitre, Guadeloupe, Martinique
Cancer Registry, UF Pôle de Cancérologie Hématologie Urologie
Pathologie, University Hospital of Martinique, Fort-de-France, Martinique,
General Cancer Registry of Guadeloupe, Department of Oto-Rhino-
Laryngology and Head and Neck Surgery, University Hospital of
Guadeloupe, Pointe-à-Pitre, Guadeloupe, France
11.35 – 11.50 Coffee Break
11.50 – 12.20 ISBS Plenary Lecture 6: UPDATE ON CANNABIS NEUROBIOLOGY. M

Fraites, St. Lucia, WI
12.20 – 12.55 ISBS Special Focus Lecture 7: STRESS INDUCED CHRONIC FATIGUE
- REJUVENATING ABILITIES OF LICORICE ROOT [Glycyrrhiza glabra].
G St. Rose, ISBS Fellow, Managing Director Eden Herbs, Integrative
Health Care Consultant and Herbalist, Creative Health Center, St. Lucia, WI
12.55 - 01.15 GENERAL DISCUSSION AND CONCLUDING REMARKS
DAY 3. Thursday, January 18, 2018
SOCIAL AND EDUCATIONAL TOURS

ABSTRACTS
DAY 1. Tuesday, January 16, 2018

CONFERENCE OPENING REMARKS. BRIEF INTRODUCTION TO THE HISTORY OF ISBS

AND CBRD. WELCOMING ADDRESSES
ISBS Lecture 1: PROTEIN KINASE C IN THE PATHOPHYSIOLOGY OF BIPOLAR ILLNESS:

A POTENTIAL BIOLOGICAL MARKER. GN Pandey, ISBS Fellow, University of Illinois at
Chicago, Department of Psychiatry, Chicago, IL, USA
INTRODUCTION: Lithium is a mood-stabilizing drug effective in the treatment of bipolar (BP)

disorder. However, its mechanism of action is unclear. Several studies suggest that lithium inhibits
the expression and activity of protein kinase C (PKC), suggesting that PKC abnormalities may be
associated with the pathophysiology of BP illness. PKC is an important enzyme of the
phosphoinositide (PI) signaling pathway and is involved in many neuronal functions. To examine
the role of PKC in BP illness, we determined PKC in platelets of BP and depressed (MDD)
patients and in the postmortem brain of BP and schizophrenic (SCZ) subjects and normal control
(NC) subjects. METHODS: PKC activity was determined both in the platelets and postmortem
brain. The protein expression of PKC isozymes was determined using Western blot, and mRNA
using real-time RT-polymerase chain reaction (qPCR). RESULTS AND DISCUSSION: We
observed that protein expression of PKC isozymes (PKC α, PKC βI and PKC βII) was significantly
decreased in platelets from BP but not from MDD patients during the drug-free period. To
examine if similar changes occur in the brain, we determined protein and mRNA expression of
PKC isozymes in the prefrontal cortex (PFC), cingulate cortex (CG) and temporal cortex of BP,
SCZ, and NC subjects. We found that protein expression of several PKC isozymes, such as PKC
α, PKC βI, PKC βII, and PKC ε were significantly reduced in the PFC, cingulate (CG) and
temporal cortex of BP patients compared with NC subjects. We also observed that both protein (in
membrane and cytosol fractions) and mRNA expression of PKC α, PKC βI, PKC βII, PKC γ, PKC
δ, and PKC ε was significantly decreased in PFC and CG of BP but not SCZ patients. We did not
find significant changes in mRNA levels of other PKC isoforms, such as PKC θ, PKC η, PKC ζ,
PKC ι. These studies suggest that abnormalities of some specific PKC isoforms may be
associated with the pathophysiology of BP illness and that these PKC isoforms may be
appropriate targets for developing more effective treatments for BP disorders. RESEARCH
SUPPORT: US National Institutes of Health (NIH) grants RO1MH077254 and RO1MH56528.
ISBS Lecture 2: CELL-TYPE SPECIFIC MECHANISMS OF GENE-ENVIRONMENT

INTERACTION IN PSYCHIATRIC DISORDERS. M Pletnikov, ISBS Fellow, Johns Hopkins
University School of Medicine, Baltimore, MD, USA
Multiple adverse environmental factors contribute to the pathogenesis of psychiatric disorders by

interacting with genetic risk factors. We modeled relevant gene-environment interactions in mice
with expression of mutant Disrupted-In-Schizophrenia 1 (DISC1) in neurons or astrocytes. We
exposed these mutant mice to prenatal immune activation or environmental toxins, or cannabis
during adolescence. We evaluated the neurobehavioral, histopathological, neuroimmune, and
molecular phenotypes in adult mice. We found that mice with neuronal expression of mutant
DISC1 developed the brain and behavioral alterations consistent with aspects of mood disorders
following prenatal immune activation, and schizophrenia-like abnormalities treatable with D-serine
treatment following developmental exposure to low doses of Pb2+. Chronic adolescent cannabis
(tetrahydrocannabinol) exposure of mice expressing mutant DISC1 in neurons exacerbated
deficient fear conditioning and synergistically decreased c-Fos expression induced by cue-
dependent fear memory retrieval. The similar adolescent cannabis exposure in mice expressing
mutant DISC1 in astrocytes led to lasting cognitive impairment and decreased number of
parvalbumin-positive neurons in adult mice. These behavioral and neuroanatomical changes were
restored in DISC1 mice after doxycycline treatment to shut down expression of mutant DISC1.
Our studies indicate that common and cell type specific changes could explain heterogeneous
manifestations of gene-environment interactions consistent with variable symptoms of psychiatric
disorders.
THE EFFECTS OF MINDFULNESS-ORIENTED RECOVERY ENHANCEMENT ON

ALLOSTATIC MECHANISMS IN STRESS, PAIN, AND ADDICTION. E Garland, University of
Utah, Salt Lake City, UT, USA
INTRODUCTION: Chronic pain results in stress-induced neuroplastic changes to the extended

amygdala that are further exacerbated by addictive behavior, resulting in an allostatic state
marked by hypersensitivity to stress and aversive stimuli coupled with a downward shift in
responsiveness to natural rewards. This stress-induced hedonic dysregulation may represent a
crucial tipping point leading to full blown addiction. Novel therapies that target allostatic
mechanisms may be an effective means of remediating stress and addiction. METHODS: To test
this hypothesis, we examined psychophysiological data from a randomized controlled trial of
Mindfulness-Oriented Recovery Enhancement (MORE), a cognitive training intervention designed
to reduce chronic pain and prescription opioid misuse. Chronic pain patients (N = 115) were
randomized to either a MORE group (n = 57) or a supportive therapy group (n = 58). MORE
sessions involved training in mindfulness, reappraisal, and savoring skills designed to modulate
self-regulation of stress reactivity and enhance responsiveness to natural rewards. Stress arousal,
chronic pain symptoms, opioid craving, and opioid misuse were assessed pre- and post-
intervention, as well as at 3-month follow-up. Participants completed a psychophysiological
protocol that assessed attentional and autonomic responses during attention to threat-related,
opioid, and natural reward cues. RESULTS: Participants in the MORE intervention reported
significantly greater reductions in stress arousal and pain, as well as significantly greater
decreases in opioid craving and opioid misuse, than support group participants.
Psychophysiological measures indicated that MORE participants exhibited decreased attentional
bias to stressful, threatening cues coupled with improvements in cardiac-autonomic
responsiveness to natural reward cues. Increases natural reward responsiveness were
associated with decreased opioid craving and misuse. DISCUSSION: Study findings provide
evidence that MORE may modulate allostatic mechanisms, thereby reducing sensitivity to stress
and pain while increasing sensitivity to natural reward. The MORE intervention may be a
promising treatment for stress and addiction. RESEARCH SUPPORT: US National Institutes of
Health (NIH).
SYMPOSIUM 1. ZUKOWSKA SYMPOSIUM ON BIOLOGICAL PSYCHIATRY.

CHAIR: AV KALUEFF (USA)
INTRODUCTION: PROFESSOR ZOFIA M ZUKOWSKA
Prof. ZOFIA M. ZUKOWSKA (1949-2012) received her M.D. and Ph.D.,

trained in cardiovascular medicine at the Warsaw Medical Academy
(Poland). She pursued post-doctoral training at the NIH, working with
such renowned scientists as Irwin I. Kopin, Scientific Director of NINDS,
and Julie Axelrod, a Nobel Laureate. During this research period, her
interest in stress and neuropeptides became galvanized. For the 25
years, she was a professor (and, later Chair) of the Department of
Physiology and Biophysics at Georgetown University, before moving to
the University of Minnesota as the Director of Stress Physiology Center.
Her research examined how stress affects cardiovascular and
metabolic health and diseases, and the role of peptides, in particular
neuropeptide Y (NPY), a sympathetic neurotransmitter and stress
mediator. She was the first to determine that NPY mediates stress-
induced prolonged vasoconstriction and vascular mitogenic and pro-
atherosclerotic effects (via Y1 receptors) and potent angiogenic actions
(via Y2 receptors), establishing the role of NPY in ischemia,
retinopathy, tumors and obesity. Professor Zukowska (or Zosia, as she
was known and admired by many) was a good friend and a strong supporter of the ISBS, serving as a
regular plenary speaker at our conferences. Her scientific vision, extraordinary creativity, kindness to
colleagues, and the talent to be daring, continue to inspire all her ISBS colleagues and their research. This
regular ISBS symposium continues Zofia’s scientific legacy in the field of biological psychiatry of stress.
THE IMPACT OF A BEHAVIORAL INTERVENTION ON FAMILY CAREGIVERS’ C-REACTIVE

PROTEIN. PR Sherwood, HS Donovan, L Terhorst, A Marsland, BA Given and CW Given,
University of Pittsburgh, Pittsburgh, PA, USA
INTRODUCTION: Several decades of research have linked family caregiver distress to

psychological distress and several studies have also linked providing care to altered immune
function in family caregivers. Although caregiver interventions have shown moderate success in
reducing caregivers’ psychological distress, the impact of these interventions on biological
outcomes is relatively unknown. The purpose of this analysis was to determine whether an 8-
week web and telephone based behavioral intervention delivered by nurses would affect
circulating levels of C-reactive protein (CRP) in caregivers of persons with a primary malignant
brain tumor (PMBT). METHODS: Family caregivers (n=48) of persons with PMBT were
randomized into two groups, one who received access to an internet site with evidence based
neuro-oncology information (enhanced care as usual, ECAU), and the other who received the
eight-week behavioral intervention. In-home visits were conducted to collect plasma for analysis
of caregivers’ C-reactive protein (CRP) at baseline and at the end of the intervention. CRP was
analyzed using high sensitivity CRP with laser nephelometry. A generalized linear model with
gamma distribution evaluating group by time changes in CRP from baseline to 4 months was
conducted controlling for gender, age, baseline CRP, relationship to the care recipient, number of
comorbid conditions, cardiac medication, alcohol use, and smoking status. RESULTS AND
DISCUSSION: The majority of caregivers were female (68%) with a mean age of 52 (SD=11);
44% had a pre-existing history of cardiac conditions. When CRP values were examined over time,
there was a significant (p=0.03) group by sex interaction in that females who received the
intervention displayed a decrease in CRP over time from baseline (1.11mg/L) to the end of the
intervention (0.88mg/L). Participants in the ECAU group displayed a rise in CRP levels over time
doubling from 0.63mg/L to 1.30mg/L. This intervention effect remained significant after controlling
for potential covariates. Additional responder analyses will be presented to compare the
percentage of participants in each group who moved from low level of risk for coronary disease
(CRP<1.0mg/L) to a moderate level of risk for coronary disease (CRP 1.0-3.0mg/L), stayed the
same, or increased from low to high risk. Preliminary analyses support the relationship of
psychological and biological variables and also underscore the potential to affect overall physical
health through behavioral interventions targeting stress reduction. RESEARCH SUPPORT: US
National Institutes of Health (NIH), National Institute of Nursing Research grant R01-NR013170.
ASSOCIATION BETWEEN EARLY AND RECENT LIFE STRESS AND DNA METHYLATION -
EPIGENOME-WIDE ASSOCIATION STUDY. WL Dragan, A Sokołowski, P Stawiński, P
Gasperowicz, G Kostrzewa and R Płoski, Interdisciplinary Centre for Behavioural Genetics
Research, Faculty of Psychology, University of Warsaw, Departments of Medical Genetics, and
Forensic Medicine, Medical University of Warsaw, Warsaw, Poland
Several lines of evidence indicate that early and recent life stress may impact the development of
psychopathology. DNA methylation is the potential mediating mechanism underlying this effect.
Our study aimed to investigate possible links between early and recent life stress and DNA
methylation profiles in an epigenome-wide manner. The studied group includes 90 participants
(47 male and 43 female) aged 18 – 25 years (M = 21.6; SD = 1.81) selected from the group of
503 subjects by the Early Life Stress Questionnaire (ELSQ) and Recent Life Changes
Questionnaire (RLCQ) scores. The DNA methylation status was analyzed using array technology
in the DNA derived from lymphoblastoid cells. We will present data on differences in methylation
status of single CpG sites between groups differing in the level of stress as well as pathway
analysis results. We will discuss the obtained results in the light of inoculation and sensitization
model of the impact of stress. RESEARCH SUPPORT: This study was supported by the National
Science Center, Poland (grant 2014/14/E/HS6/00413) and internal funds of the University of
Warsaw.
DOES RUMINATION ALLOW TO PREDICT EMOTIONAL DISORDERS? M Dragan, University

of Warsaw, Warsaw, Poland
INTRODUCTION: Rumination – a pattern of prolonged negative thinking – is associated with the

worsening of negative mood states and prolonging and deepening episodes of depression as well
as increasing the risk of developing subsequent episodes. However, in the metacognitive self-
regulatory function model it is also hypothesized to serve as a transdiagnostic vulnerability factor
in the development and maintenance of various disorders. The aim of presented study was to test
hypothesis that tendency to rumination is predictive for diagnosis of Axis I disorders. METHODS:
At the first stage a large sample of participants (N=1200) fulfilled three questionnaires measuring
tendency to rumination and dysfunctional metacognition. From this sample, 90 participants were
selected to the second stage of the study. 45 of them were classified as ruminators, and 45 as
non-ruminators. Both groups of participants were examined using DSM-IV-R SCID-I clinical
interview (belonging to the groups was blinded). RESULTS AND DISCUSSION: Results confirm
an assumption that diagnosis of Axis I disorders (mainly depression and anxiety disorders) can be
predicted on the basis of tendency to rumination. Diagnosis of emotional disorders was
significantly more frequent in the group of ruminators. Moreover, ruminators reported also more
sub-clinical symptomatology. These findings can be interpreted as a confirmation of basic
assumptions of transdiagnostic metacognitive model of psychopathology. RESEARCH
SUPPORT: The National Science Centre in Poland.
ISBS Special Focus talk: UNDERSTANDING ANTIDEPPRESSANT DISCONTINUATION

SYNDROME (ASD) – BRIDGING CLINICAL AND PRECLINICAL FINDINGS. KN Zabegalov, TO
Kolesnikova, SL Khatsko, AD Volgin, OA Yakovlev, TG Amstislavskaya, PA Alekseeva, DA
Meshalkina, AJ Friend, W Bao, KA Demin and AV Kalueff, ISBS Fellow, Ural Federal University,
Yekaterinburg, Institute of Translational Biomedicine, St. Petersburg State University, St.
Petersburg, Laboratory of Translational Biopsychiatry, Research Institute of Physiology and Basic
Medicine, Department of Neuroscience, Novosibirsk State University, Novosibirsk, Russia; School
of Pharmacy, Southwest University, Chongqing, China; Institute of Experimental Medicine,
Almazov National Medical Research Center, St. Petersburg, Russia; Tulane University School of
Science and Engineering, New Orleans, The International Zebrafish Neuroscience Research
Consortium (ZNRC), ZENEREI Research Center, Slidell, LA, USA
Antidepressant drugs are currently the most prescribed class of medications. In addition to
treatment resistance and side effects of antidepressants, their clinical use is further complicated
by antidepressant discontinuation syndrome (ADS). ADS typically occurs in patients following the
interruption, dose reduction, or discontinuation of antidepressant drugs. ADS resembles a
classical drug withdrawal syndrome, albeit differing from it because antidepressants generally do
not induce addiction. The growing clinical importance and prevalence of ADS necessitate novel
experimental (animal) models of this disorder. Currently available preclinical models of ADS are
mainly rodent-based, and study mostly serotonergic antidepressants and their combinations.
Here, we systematically assess clinical ADS symptoms and discuss current trends and challenges
in the field of experimental (animal) models of ADS. We also outline basic mechanisms underlying
ADS pathobiology, evaluate its genetic, pharmacological and environmental determinants, and
suggest how using animal models of ADS may help generate important translational insights into
human ADS condition, its prevention and therapy. RESEARCH SUPPORT: The Russian
Foundation for Basic Research (RFBR).
VIDEO-PRESENTATION: ART MEETS SCIENCE. D Raytchev, D Raytchev Art, London, UK

DAY 2. Wednesday, January 17, 2018

PAIN MANAGEMENT IN THE CANCER PATIENT. WCV Parris, Department of Anesthesiology,

Duke University Medical Center, Durham, NC, USA
The goals and objectives of this presentation are to discuss the overall treatment of the cancer
patient with special emphasis on pain mechanisms and relevant therapies. To that end, the
following objectives would be emphasized: 1. The background and epidemiological issues related
to cancer pain, 2. Classification and mechanisms of cancer pain syndromes, 3. Therapeutic
options for cancer pain syndromes. Issues relating to the patient, the providers and the healthcare
system would be discussed in the context of providing care for the cancer pain patient.
SYMPOSIUM 2. LAPIN SYMPOSIUM ON TRANSLATIONAL BIOMEDICINE.

CHAIR: MV PLETNIKOV (USA)
INTRODUCTION: PROFESSOR IZYASLAV P LAPIN
This regular ISBS symposium is dedicated to Professor Izyaslav ‘Slava’ P.

Lapin (1930-2012), a true pioneer of experimental neuro-
psychopharmacology and biological psychiatry. Slava Lapin graduated from
Pavlov Medical School in St. Petersburg, and shortly after receiving PhD,
was invited in 1960 to establish the first psychopharmacology laboratory at
the Bekhterev Psychoneurological Institute. The most important scientific
contribution of Prof. Lapin was establishing the link between serotonin levels
and mood-elevating (thymoleptic) action of antidepressants. He suggested
that enhanced central serotonergic tone is essential for the mood-elevating
effects of antidepressants. Lapin’s serotonin hypothesis of antidepressant
action, published (together with G Oxenkrug) in Lancet in 1969, became one
the most cited papers published in this journal in the last 50 years. Lapin’s
studies have contributed greatly to the development of newest serotonergic
antidepressants, such as SSRIs, currently representing the most prescribed
group of psychotropic drugs in the world. Prof. Lapin was also the first to report the neuroactive effects of
kynurenine and its derivatives – a discovery that opened another rapidly expanding area of glutamatergic
psychopharmacology. A talented professional musician, prolific writer, painter, and an enthusiastic athlete,
Prof. Lapin was a strong supporter of ISBS, and generously shared his knowledge with colleagues and
students at our “Stress and Behavior” conferences and ISBS summer schools. His enthusiasm, friendship,
generous support of junior colleagues, and the deep knowledge as both a clinical and experimental
neuropharmacologist (‘humanists’ and ‘animalists’, as he called them), made a long-lasting impact on his
colleagues and students. This ISBS symposium will continue Lapin’s scientific legacy in the field of
biological psychiatry and translational neuroscience.
ISBS Presidential Lecture 4: ZEBRAFISH MODELS OF DRUG ABUSE AND STRESS. AV

Kalueff, ISBS Fellow, ZENEREI Research Center, Slidell, LA, USA; Southwest University,
Chongqing, China; St. Petersburg State University, St. Petersburg, Ural Federal University,
Ekaterinburg, Russia
Chronic stress is the major pathogenetic factor of human anxiety and depression. Drug abuse is
commonly comorbid with stress, anxiety and depression. Zebrafish (Danio rerio) have recently
become a novel popular model species for neuroscience research and CNS drug discovery. The
utility of zebrafish for mimicking human affective disorders is also rapidly growing. Here, we
summarize zebrafish models of acute and chronic stress, and the sensitivity of zebrafish to major
drugs of abuse. Together, these findings support zebrafish as a useful in-vivo model of stress and
drug abuse, also calling for further cross-species studies of both shared/overlapping and distinct
neurobiological responses. Finally, we overview recent findings on the role of environmental
enrichment in zebrafish (with a specific focus on auditory enrichment), and discuss potential
strategic areas of research in this field.
ISBS Plenary Lecture 5: HIV PREVENTION, TREATMENT AND CARE AMONG PEOPLE
WHO USE STIMULANT DRUGS AND THEIR SEXUAL PARTNERS, AN IMPLEMENTATION
GUIDE. M Day, ISBS Fellow, Caribbean Drug and Alcohol Research Institute (CDARI), Castries,
St. Lucia
BACKGROUND: The context of drugs, drug taking and BBV has changed in the past 4 decades
with the increase in use of stimulants and new psychoactive substances (NPS). The use of and
injection of stimulants and NPS has lead to the growth of HIV and other BBV in populations not
specifically supported by services designed for opioid users. Other subpopulations of stimulant
users who's risk of HIV comes from sexual transmission rarely encounter community based HIV
prevention initiatives. DESCRIPTION: People who use stimulants include individuals who use,
either by injecting or non-injecting routes, cocaine and it's smokable derivatives; amphetamine-
type stimulants (ATS) or any of the other varieties of new psychoactive stimulant (NPS) drugs.
The injection of stimulants differs from that of opioids and is associated with rapid repeated
patterns of injecting that requires tailored safer injecting advice and access to adequate stocks of
injecting equipment. HIV epidemics among people who use stimulants, are particularly prevalent
among among female, MSM and trans sex workers and MSM engaged in concurrent sex parties
and other high risk sexual behaviour. HIV vulnerability increases when the interaction of poverty,
marginalisation, sex work intersects with historic epidemics and elevated viral loads, particularly in
communities of people who inject drugs. The collective use of drugs to enhance sexual
experience, the use of stimulants to extend working hours, and immunosuppressant qualities of
stimulants co-exist to create conditions that can exacerbate risk of transmission of HIV.
LESSONS LEARNED: The promotion and development of services for people who use stimulant
drugs is often taking place within contexts where their drug use attracts high levels of stigma,
discrimination and criminalisation, constituting major barriers to access and utilise services. When
these individuals are also members of other key population groups, such as MSM or women who
present as sex workers, the stigma and discrimination comes from both the external society and
their own community. CONCLUSIONS/NEXT STEPS: To address these issues requires a
targeted response tailored to the needs of key populations engaged in stimulant use including
community access to harm reduction commodities, condom and lubricant distribution, HIV/STI
testing and treatment, and access to ART, PEP and PREP. Country of research: Antigua and
Barbuda, Dominica, Dominican Republic, Jamaica, Martinique, Saint Kitts and Nevis, Saint Lucia,
Saint Vincent and the Grenadines, Trinidad and Tobago. Key population targeted: People who
inject drugs, Men who have sex with men, Transgender people.
PREVALENCE OF ORAL HPV INFECTION AMONG HEALTHY INDIVIDUALS AND HEAD

AND NECK CANCER CASES IN THE FRENCH WEST INDIES. A Auguste, S Gaete, C
Herrmann-Storck, L Michineau, C Joachim, J Deloumeaux, S Duflo and D Luce, INSERM U 1085-
IRSET (Research Institute for Environmental and Occupational Health), Pointe-à-Pitre,
Guadeloupe, University of Rennes, Rennes, Centre de Ressources Biologiques de Guadeloupe,
Laboratory of Microbiology, University Hospital of Guadeloupe, Pointe-à-Pitre, Guadeloupe,
Martinique Cancer Registry, UF Pôle de Cancérologie Hématologie Urologie Pathologie,
University Hospital of Martinique, Fort-de-France, Martinique, General Cancer Registry of

Guadeloupe, Department of Oto-Rhino-Laryngology and Head and Neck Surgery, University
Hospital of Guadeloupe, Pointe-à-Pitre, Guadeloupe, France
INTRODUCTION: Human papillomavirus (HPV) is known to play a role in the development of

head and neck squamous cell carcinomas (HNSCC) and to date, no study has reported on the
association oral HPV infection and HNSCC in the Caribbean. The objective was to determine the
prevalence of oral HPV infection in the French West Indies (FWI), overall and by HPV genotypes,
among HNSCC cases and healthy population controls. METHOD: We used data from a
population-based case-control study conducted in the FWI. The prevalence of oral HPV was
estimated separately among 100 HNSCC cases (mean age 59 years) and 308 population controls
(mean age 57 years). Odds ratios (OR) and 95% confidence intervals (CI) were estimated using a
logistic regression adjusting for age, sex, tobacco and alcohol consumption, to assess the
association between oral HPV infection and HNSCC. RESULTS AND DISCUSSION: Prevalence
of oral HPV infections was 26% in the controls (30% in men and 14% in women) and 36% in the
HNSCC cases (36% in men, 33% in women). HPV52 was the most commonly detected genotype,
in cases and in controls. The prevalence of HPV16, HPV33 and HPV51 was significantly higher in
cases than in controls (p=0.0340, p=0.0472 and 0.0144 respectively). Oral infection with high-risk
HPV was associated with an increase in risk of HNSCC (OR=1.99, 95% CI 0.95- 4.15). HPV16
was only associated with oropharyngeal cancer (OR=16.01, 95% CI 1.67 –153.64).
CONCLUSION: This study revealed a high prevalence of oral HPV infection in this middle-aged
Afro-Caribbean population, and a specific distribution of HPV genotypes. These findings may
provide insight into HNSCC aetiology specific to the FWI. RESEARCH SUPPORT: Grant from the
"Ligue contre le Cancer, comité d'Ille-et-Vilaine" (to AA). This study was funded by the French
National Cancer Institute (Institut National du Cancer) and the Cancéropôle Ile-de-France.
ISBS Plenary Lecture 6: UPDATE ON CANNABIS NEUROBIOLOGY. M Fraites, St. Lucia, WI
I will outline the earliest known history of cannabis and some of the most significant studies and
discoveries made in this field, showing that humans have long been inextricably linked with
cannabis. The first isolation of the THC molecule from cannabis was a breakthrough that led to
the discovery and understanding of the endocannabinoid system. However, we have insight, but
not a full understanding, of how the endocannabinoid system can be used to prevent, diagnose
and treat a disease, defect or symptom of illness. The endocannabinoid system is comprised of
receptors, their endogenous ligands, and the proteins synthesized to degrade them. Research
has identified various cannabinoid receptors in the brain and immune cells which respond to
agonists or inverse agonists which may be endogenous, synthetic or phyto-derived. The
cannabinoid receptors are abundant in the mammalian brain. Appropriate levels of cannabinoids
appear to be required to support pregnancy, and breast milk contains cannabinoids for the
development and growth of the newborn. With a firm understanding of the endocannabinoid
system and the 60+ cannabinoids, we can prevent or eliminate the few negative possible
outcomes of Cannabis use and maintain optimum health.
ISBS Special Focus Lecture 7: STRESS INDUCED CHRONIC FATIGUE - REJUVENATING

ABILITIES OF LICORICE ROOT [Glycyrrhiza glabra]. G St. Rose, ISBS Fellow, Managing
Director Eden Herbs, Integrative Health Care Consultant and Herbalist, Creative Health Center,
St. Lucia, WI
The hypothalamic-pituitary-adrenal (HPA) axis functioning is the major key hormonal stress
system of the body. The adrenal glands are the body’s response system for emotional, physical or
chemical stress. They produce hormones (adrenaline and cortisol) to help responses to stress.
When the adrenals are required to constantly respond to stress, they eventually have to struggle
to produce cortisol and adrenaline (and other important hormones). This pattern depletes the
adrenals and leads to adrenal exhaustion which can lead to chronic fatigue syndrome. Licorice
root (Glycyrrhiza glabra), alternatively known as liquorice root, is a commonly used herbal
medicine. “Chinese licorice”, Glycyrrhiza uralensis is the second variety. Licorice was found
to help the body to more efficiently regulate cortisol (the main stress hormone) and to reverse the
resultant chronic fatigue.
GENERAL DISCUSSION AND CONCLUDING REMARKS
DAY 3. Thursday, January 18, 2018
SOCIAL AND EDUCATIONAL TOURS

THE INTERNATIONAL “STRESS

AND BEHAVIOR” SOCIETY (ISBS)
ISBS is the international society of experts working with a wide range of topics in the field of
translational neuroscience, neurobehavioral sciences, biopsychology and biopsychiatry, with a
particular focus on stress, stress-related neurobehavioral phenotypes, their neural, molecular and
genetic mechanisms, as well as stress-evoked neuropsychiatric disorders.
Anyone with an interest in stress-related human or animal behaviors, neurobehavioral disorders

and their mechanisms, wishing to join ISBS, can do so by paying dues. Payment can be made
following sending the e-mail form and payment request to the ISBS Secretariat at
info@stressandbehavior.com. Once the form and the payment have been received, you will
receive a membership confirmation.
Membership:
Regular membership dues are $100.00 for the period of three years, or $60.00 for the period of
one year. Student (undergraduate and graduate) membership dues are $60.00 for the period of
three years.
• Regular membership benefits include a $50.00 discount for registration for any of the ISBS
Conferences, symposia, workshops and summer schools.
• Student members will benefit from a $25.00 discount for registration for any of the ISBS
Conferences, symposia, workshops and summer schools.
• Membership cycle starts January 1st. ISBS Members benefit from reduced STRESS,
BRAIN & BEHAVIOR journal subscription fees: $70.00 (regular member), $55.00 (student
member).
ISBS Membership application form (please fill in and send by e-mail to the ISBS Secretariat at
info@stressandbehavior.com, with the subject ‘ISBS Membership request’)
Name, Family name:

Position/Title:
Institute/Company:
Category - please select one:
• Regular member, 3-year term ($ 100.00)
• Regular member, 1-year term ($ 60.00)
• Student member, 3-year term ($ 60.00)
Address (affiliation): City:
Postal code: State: Country:
Phone, Fax:
E-mail address: www:
www.stress-and-behavior.com
info@stressandbehavior.com
THE INTERNATIONAL “STRESS AND BEHAVIOR” SOCIETY

(ISBS)
Fellows of ISBS:
The ISBS Fellowship (with Life membership) is the highest honor bestowed by the International Stress
and Behavior Society. It is awarded annually to international scholars, in recognition of their
contribution to clinical or translational neuroscience, biological psychiatry and stress physiology
research and/or education, as well as for their long-standing support of the ISBS mission and its
national, regional or international programs.
Dr. Mikhail Aghajanov (Yerevan Medical University, Armenia), 2015

Dr. Elliott Beaton (University of New Orleans, USA), 2015
Dr. Evgeniy Budygin (Wake Forest Medical Center, USA), 2014
Dr. Marcus Day (Caribbean Drug and Alcohol Research Institute, St. Lucia), 2017
Dr. David Echevarria (University of Southern Mississippi, USA), 2014
Dr. Alexey Egorov (Sechenov Institute, Russia), 2014
Dr. Irina Ekimova (Sechenov Institute, Russia), 2013
Dr. Raul Gainetdinov (Italian Institute of Technology, Italy), 2013
Dr. Allan Kalueff (ZENEREI Institute, USA), ISBS President, 2013
Dr. Victor Klimenko (Institute of Experimental Medicine, Russia), Vice-President, 2013
Dr. Mamiko Koshiba (Tokyo University of Agriculture and Technology, Japan), 2014
Dr. Shun Nakamura (Tokyo University of Agriculture and Technology, Japan), 2014
Dr. Tatyana Nevidimova (National Mental Health Institute, Russia), 2014
Dr. Yuriy Pastuhov (Sechenov Institute, Russia), 2013
Dr. Ghanshyam Pandey (University of Illinois at Chicago), 2017, USA
Dr. Mikhail Pletnikov (Johns Hopkins University, USA), 2015
Dr. Tatyana Sollertinskaya (Sechenov Institute, Russia), 2013, deceased
Dr. Adam Stewart (ZENEREI Institute, USA), 2015
Dr. Tatyana Strekalova (Maastricht University, Netherlands), 2014
Dr. Gilbertha St. Rose (Eden Herbs, St. Lucia), 2015
Dr. Oleg Syropiatov (UAPO, Ukraine), 2013
Dr. Sergei Tsikunov (Institute of Experimental Medicine, Russia), 2014
Dr. Jason Warnick (Arkansas Tech University, USA), 2014
Dr. Louis Newman (Destiny Medical School, St. Lucia), 2016
Dr. Urban Seraphin (Allied Health Council, St. Lucia), 2016
Dr. Dusko Kozic (University of Novi Sad, Serbia), 2016
Dr. Petr Shabanov (Institute of Experimental Medicine, Russia), 2016
The International Zebrafish

Neuroscience Research
Consortium (ZNRC)
The main goal of ZNRC is to promote zebrafish neuroscience research. Created in February
2010, ZNRC offers excellent networking opportunities and peer support for active zebrafish labs.
ZNRC currently includes the following labs/PIs:
• Allan Kalueff, USA/Russia/China

• Georgianna Gould, USA
• Oliver Braubach, Canada/Korea
• Anderson Manoel Herculano, Brazil
• Caio Maximino, Brazil
• David Echevarria, USA
• Joseph Schroeder, USA
• Jason Warnick, USA
• Dominic Wright, Sweden
• Carla Denise Bonan, Brazil
• Mônica Ryff Moreira Roca Vianna, Brazil
• Wei Weng, USA
• Bally-Cuif, France
• Julian Pittman, USA
• Denis Rosemberg, Brazil
• Diogo Onofre Souza, Brazil
• Diogo Losch de Oliveira, Brazil
• Raul Bonne Hernandez, Brazil
• William Norton, UK
• Adam Michael Stewart, USA
• Lucas Noldus, Netherlands
• Jeremy Ullmann, Australia
• and others
ZNRC is currently involved in inter-lab academic exchanges, zebrafish scholarly publications, and
organizing zebrafish-related symposia and conferences.
If your lab is interested in joining ZNRC, please email your request and PI’s CV to the ZNRC
coordinator at info@stressandbehavior.com
Dear Colleagues and Friends,

It is our great pleasure to announce the 8th Mind-Body Interface (MBI) International Symposium is
to be held at China Medical University, Taichung, Taiwan in October 2018. The tentative dates
are Oct. 25-27, 2018.
The main theme of MBI symposium is "From Molecule to Mind：Bridging the Gap between Bench
and Bedside in Neuroscience", which will comprise keynote speech, plenary sessions and poster
sessions. Bursaries for overseas participants are provided. For more information regarding the
symposium updates and abstract submission, please follow up our website: www.mbi2018.org.
The MBI Int’l symposium is organized by Taiwanese Society for Nutritional Psychiatry and it has
been vigorously promoting a global agenda of translational medicine by encouraging
interdisciplinary research, and integrating biomedical discovery and development focused on
patients, to provide better care and service in the field of brain health. The meeting is featured
with a broad spectrum of research, including basic science and the biological processes and
factors underlying mental illness, including immunology, metabolic processes and molecular
science. Furthermore, there will be a strong focus on neuroimaging, personalized medicine,
lifestyle intervention, brain-gut-microbe axis, dietary intervention, health promotion and disease
management, epidemiology and population studies, as well as Chinese medicine in mental health.
This year (2018), we are especially delighted to welcome our international partners to actively
take part in the symposium, including International Stress and Behavior Society (ISBS), and
Psychoneuroimmunology Research Society (PNIRS-Asia Pacific). With the inspiration and
intimate interaction from society members worldwide, and the great hospitality and social events
every year, the 8th MBI Int'l Symposium is guaranteed to be as successful as it has been in the
previous years.
※ 2017 MBI Int’l Symposium Photos: https://goo.gl/YG9uYv
※ 2017 MBI Int’l Symposium Website: www.mbi2017.org

Metris BV
Netherlands, Kruisweg 829c, 2132NG Hoofddorp
Тel: +31235623400, Fax: +31235623425,

e-mail: info@metris.nl, web: www.metris.nl
Metris is a leading manufacturer of advanced systems for animal behavior analysis (in-vivo
experiments) that are sold globally. Main products are: LABORAS, SONOTRACK and
SMARTCHAMBER.
LABORAS is an innovative system that automates behavior scoring and analysis of small
laboratory animals. The system tracks the XY-position and simultaneously identifies more than 18
validated stereotypical and normal behaviors in mice and rats. Laboras does not use video or
infrared beams! There are over 300 publications about the use of Laboras by several leading
researchers, pharmaceutical companies, CRO’s and leading universities from around the world.
SONOTRACK is an advanced system to record, analyze and playback ultrasound vocalizations.

The system is highly valued for research in Pain, Stress, Anxiety, Fear, Memory, Learning,
Developmental (Neuro) Toxicity and Social Interaction tests. Sonotrack is the best ultrasound
vocalization system on the market today because of its full spectrum USV recording (15 kHz to
125 kHz) characteristics, extremely low noise, long duration recording capability and reliable fully-
automatic detection of rodent calls.
SMARTCHAMBER provides a sound isolated, ventilated and light controlled environment to

perform high performance ultrasonic vocalization experiments. The chamber includes an
ultrasonic microphone and the interior of the chamber effectively removes sound echo's, external
noise and sounds and magnetic fields. SmartChamber can be seamlessly integrated with our
product Sonotrack.
DSI Data Sciences International is the leading manufacturer for implantable monitoring devices
used in preclinical studies. The devices acquire cardiovascular, CNS and respiratory data from
freely moving animals in a stressfree environment.
In the CIS countries, Metris sells modular vivariums and laboratory cabins and various vivarium
and laboratory equipment, including cages, Individual Ventilated Cages (IVC racks), workstations,
washing machines, wireless equipment for animal identification and temperature registration,
systems for wireless measurement of physiology parameters (ECG, EEG, EMG, Blood pressure,
Temperature, Respiration) and Sleep Analysis software.
Metris is exclusive distributor for DataSciences International (DSI-telemetry), LabProducts, Bio

Medical Data systems (BMDS), Instech, Buxco and Kissei Comtec.
THE INTERNATIONAL STRESS AND BEHAVIOR

SOCIETY (ISBS)
Please join our 2018-2019 ISBS Conferences:
25th International Neuroscience and Biological

Psychiatry Conference "STRESS AND BEHAVIOR"
May 16-19, 2018, St. Petersburg, Russia
International Neuroscience and Biological Psychiatry ISBS

Symposium "TRANSLATIONAL BIOLOGICAL PSYCHIATRY"
May 23, 2018, Kiev, Ukraine
14th International Regional Neuroscience and Biological

(North America)
June 22-23, 2018, Miami Beach, FL, USA

Psychiatry Conference "STRESS AND BEHAVIOR" (Asia)
September 9-10, 2018, Yamaguchi, Japan
(in conjunction with WFSBP Kobe September 7-9, 2018)
26th International Neuroscience and Biological

May 16-19, 2019, St. Petersburg, Russia

(North America)
June 22-23, 2019, Miami Beach, FL, USA
E-mail: info@stressandbehavior.com
www.stress-and-behavior.com
Behavioural Research
Equipment
For Model Organisms
Increase lab productivity with Zantiks’s Above: Part of a suite of 24 Zantiks AD systems
installed at Queen Mary University of London (QMUL),
fully integrated and automated systems used by Dr Caroline Brennan’s Zebrafish Neurobiology
and Behavioural Genetics group.
Benefits of using the Zantiks AD and Below: Zantiks units can be used for studies of rats,
mice, adult zebrafish, larval zebrafish, Drosophila
Zantiks MWP units: and Daphnia.
� Small footprint - plus all inclusive networked units,

browser enabled
� Video tracking and recording - of single and
multiple animals
� Real-time data - easy to process and analyse
� More consistent results - highly controlled, isolated,
stable environments
� Built-in stimuli - visual, vibratory, aversive and
reward delivery
� Affordable and scalable - suitable for high
throughput studies
“ The Zantiks units have transformed our research,

reliably automating a wide range of experiments and
increasing our productivity four-fold.
Dr Caroline Brennan, QMUL
”
For info, a demo or a quote, contact – info@zantiks.com | zantiks.com
Zantiks Leaflet AW.indd 1 10/03/2017 13:35

Multiple Behavioural
Studies
Using One Versatile Unit
Available studies include: Watch your experiments live

Studies of zebrafish larvae, Drosophila and Daph- Larval zebrafish
in Zantiks MWP
nia in the Zantiks MWP unit unit in 24 well
plate assay
� Locomotor activity
� Circadian rhythm monitoring
� Toxicity, phenotyping and drug screening
� Startle response, habituation and Adult zebrafish
in Zantiks
prepulse inhibition AD unit,
approaching
initiator light in
5CSRTT
Studies of adult zebrafish and mice in
the Zantiks AD unit
� 5-choice serial reaction time task
Adult zebrafish
in Zantiks
� Matching to sample
AD unit, with
inserts for
� Shock aversion learning Y-maze
� Y-maze
� Startle response, habituation and
prepulse inhibition
Adult zebrafish
� Conditioned place preference in Zantiks AD
unit, in 4 arena
aversion assay,
baseline
View tracking videos online – zantiks.com
For info, a demo or a quote, contact – info@zantiks.com | zantiks.com
Zantiks Leaflet AW.indd 2 10/03/2017 13:35

Behavioral Research
Innovative tools for neuroscience, zoology, and entomology
the observer xt
The Observer® XT is the professional
and user-friendly event logging
software for the collection, analysis,
and presentation of observational
data. Used by more than 20,000
professionals worldwide, it supports
the entire workflow of a research
project and is easily extended with
different modules and a software
development kit to exactly suit your
research.
Easy to work with

Recent improvements in The
Observer XT software allow you The Observer XT: powerful and reliable annotation software to easily score behavior in detail.
to perfect your observation more
easily than ever. During the scoring
of behaviors, you can set a video occurrences of specific behaviors, with a start and stop time and duration
loop to automatically view a certain of each occurrence specified so you can use this data in other statistical
section of the video a few times programs. The Observer XT’s own statistics now include percentiles to accom-
(which, of course, can be applied modate non-normally distributed data.
to audio as well). You can also use
the quick review button for an pocket observer
instant playback of the last couple With Pocket Observer, you can score on the go! Available on handheld
of seconds. After observations are computers and Android devices, such as smartphones and tablets. Ideal for
finished, and you are viewing your studying animals in their natural habitat or in a zoo! Simply design your
results in a synchronized view with ethogram with The Observer XT on your PC, transfer it to your handheld
the video, you can directly adjust device, perform the observations, and then import the results back into
any inaccuracies. For example, say a The Observer XT to analyze your data. The new Android app now has better
behavior started a couple of seconds color schemes and options to adjust the size of the different windows.
earlier than when the behavior was
scored. Simply go to the correct
starting time in the video, go
directly to the current observation
with one mouse-click, and easily
update the starting time of that
eating behavior.
New options for statistical analysis

Another recent addition to The
Observer XT software is the find-
functionality that allows you to
Pocket Observer:
easily create and export a list of score on the go!
ethovision xt
EthoVision® XT is the ideal solution
for automated tracking and analysis
of animal movement, activity, and
behavior. From basic video tracking to
fully integrated systems that include
interactive hardware controls used in
the most sophisticated experiments –
EthoVision XT does it all. With twenty
years of experience, it has become the
industry standard, offering versatility,
powerful features, and superior detec-
tion methods.
For every situation

You can use EthoVision XT for any
EthoVision XT: for the tracking and analysis of animal movement, activity, and behavior.
animal; whether you are studying
rodents in the lab or farm animals in
their stables. As long as you can view
Additionally, video tutorials are strategically placed throughout the
your animals from above with a camera,
program, for some extra help along the way. Once you’ve set up and
EthoVision XT can detect and track
conducted your experiment, EthoVision XT offers powerful data selec-
the animal as it moves through the
tion and analysis tools to help you turn data into significant results
test arena. The unique algorithm even
and conclusions.
allows the nose point, center point, and
tail base of rodents to be detected. In company profile
addition, activity detection detects Noldus Information Technology develops innovative solutions for beha-
changes in the arena from one video vioral research on humans and animals. These can vary from industry
frame to the next. It even works in situ- standard software packages and lab equipment to fully integrated
ations where lighting is poor or when observation labs including training and support. With almost 25 years
you are using light animals on a light of experience we translate your questions into practical and proven
background or dark animals on a dark solutions and services.
background.
find out more!
Powerful yet easy to use Our other products include:
EthoVision XT offers great accessibility ▪ CatWalk™ XT — Complete system for the quantitative assessment
and allows you to set-up and perform of footfalls and gait in rats and mice.
experiments efficiently. The user guided
▪ PhenoTyper® — Instrumented home or basic cages for uninterrupted
set-up helps you choose an experiment
testing of rodents
template suited to the kind of animal
and experiment arena, such as a T-maze
▪ DanioVision™ — Complete solution for the high throughput testing
of zebrafish larvae and other very small animals in 96-well plates.
or open field. Basic settings are pre-set,
which you can fine-tune as you go. Per- ▪ And more!
forming a similar test often? Re-use your
settings by creating your own custom
template.
international headquarters north american headquarters We are also represented by a Due to our policy of continuous product improvement,
worldwide network of distributors information in this document is subject to change without
Noldus Information Technology bv Noldus Information Technology Inc.
and regional offices. Visit our notice. EthoVision, CatWalk, The Observer, DanioVision, and
Wageningen, The Netherlands Leesburg, VA, USA website for contact information. PhenoTyper are (registered) trademarks of Noldus Informa-
Phone: +31-317-473300 Phone: +1-703-771-0440 tion Technology bv. © 2015 Noldus Information Technology
bv. All rights reserved.
Fax: +31-317-424496 Toll-free: 1-800-355-9541
E-mail: info@noldus.nl Fax: +1-703-771-0441
E-mail: info@noldus.com
www.noldus.com/animal-behavior-research
TSE Systems - experienced supplier of life science research equipment for
comprehensive solutions in the fields of Metabolism, Behavior,
Physiology, Inhalation Toxicology and Telemetry
it u s at ou r booth!
Ple a s e v is
The PhenoMaster allows the assessment of metabolic, behavioral,

cognitive and physiological parameters in the homecage.
For the evaluation of rodent models in a social context, the IntelliCage

minimizes the necessity of human handling and increases reproducibility,
while the assessment of cognition in a social context.
Stellar Telemetry monitors a wide range of physiological parameters

in virtually any species.
The Multi Conditioning System is a multi-purpose modular

test platform accommodating nine behavioral paradigms for the evaluation
of learning, memory, emotion and stress-related behaviors in mice and rats.
We also offer complete solutions for a variety of Inhalation exposure

studies (in-vivo and in-vitro) with aerosols and vapors for various application
fields, e.g. pharmacology, toxicology.
MotoRater allows semi-automated evaluation of 4 different

motion modalities – over ground walking, skilled ladder walking,
wading in water and swimming – and provides fine motor kinematic
analysis tools to assess animals’ motor performance with high precision.
www.TSE-Systems.com info@TSE-Systems.com
3rd ISBS Caribbean Biomedical Research Days Jan 16-18, 2016
Johns Hopkins Animal Behavior Core
e
r
o
The Johns Hopkins School of

C
Medicine Animal Behavior Core

provides expert help in behavioral
phenotyping of genetically-
r
engineered or manipulated mice and

o
rats. The Core provides help in

i
designing and running behavioral

tests and analyzing the data. We help
v
Tests Available Include:

investigators evaluate different
a
• PPI/startle response domains of rodent behavioral

h
• Morris water maze repertoires to address the diverse

• Forced swim test phenotyping needs of the Hopkins
e
• Fear conditioning and outside community.

B
• Ultrasonic Vocalization
Detection
• Elevated Plus maze
• Radial Arm Maze
s
• Passive-avoidance
• Active-avoidance
n
• Y-maze
i
• T-maze
• Rotarod
k
• CatWalk
p
• Heat sensitization
• Open field chamber
o
• Social Interaction
H
• Tail suspension test

• Radial Arm maze
• Novel Object
s
Recognition
n
+ More Contact:
h
Dr. Mikhail Pletnikov

o
Core Director
mpletni1@jhu.edu
J
30
3rd ISBS Caribbean Biomedical Research Days Jan 16-18, 2016
31
Daniela Raytchev
London, UK
www.danielaraytchev.com
T: +44 (0)7540 297545

E: info@danielaraytchev.com
F: DaniRaytchevArt
‘Progress not Perfection’ and upcoming ‘Capital’ projects are centered around people who
currently suffer or have dealt with their addictions, whole spectrum of them. Abstract portraits of
the participants who come from all walks of life show their past experience, present state of mind
and future ambitions. Graphic nature in some cases suggests altered state of reality as well as
playful, honest and open-minded approach to discussing many times stigmatized issue.
Expressive character of the artwork relates to the fluctuating emotions, often accompanied by
anxiety and depression, that is juxtaposed against clean ‘peaceful’ linework. There is certain
beauty in capturing the chaos and vulnerabilities. Paintings include personal narratives of the
subjects who Raytchev interviews and studies over the period of several sittings before creating
the final large scale pieces.
ISBS Conference “Neuroscience of Stress”, December 1-3, 2017, Rio de Janeiro, Brazil
28

Program and Proceedings - 5th Caribbean Biomedical Research Days CBRD-2018, Jan 16-18, 2018, Rodney Bay, St. Lucia

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Program and Proceedings - 5th Caribbean Biomedical Research Days CBRD-2018, Jan 16-18, 2018, Rodney Bay, St. Lucia

Uploaded by

Copyright:

Available Formats

5th ISBS Caribbean Biomedical Research Days, January 16-18, 2018

CBRD-2018 St. Lucia, West Indies – www.stressandbehavior.com

The International Stress and Behavior Society (ISBS)

Rodney Bay, St. Lucia

IN PARTNERSHIP WITH OUR OFFICIAL SPONSORS:

09.30 – 10.00 Registration

10.00 – 10.20 CONFERENCE OPENING REMARKS. BRIEF INTRODUCTION TO THE

10.20 – 11.00 ISBS Lecture 1: PROTEIN KINASE C IN THE PATHOPHYSIOLOGY OF

11.00 - 11.40 ISBS Lecture 2: CELL-TYPE SPECIFIC MECHANISMS OF GENE-

11.40 - 12.10 THE EFFECTS OF MINDFULNESS-ORIENTED RECOVERY

12.10 – 12.40 ROUND TABLE: IMPROVING THE VALIDITY OF BIOMEDICAL

12.40 – 02.00 Lunch Break (free time)

02.00 - 03.40 SYMPOSIUM 1. ZUKOWSKA SYMPOSIUM ON BIOLOGICAL

02.00 - 02.10 INTRODUCTION: PROFESSOR ZOFIA ZUKOWSKA

02.10 - 02.35 THE IMPACT OF A BEHAVIORAL INTERVENTION ON FAMILY

03.00 - 03.25 DOES RUMINATION ALLOW TO PREDICT EMOTIONAL DISORDERS?

03.25 - 03.40 GENERAL DISCUSSION

03.40 – 04.00 Coffee Break

04.00 - 04.30 ISBS Special Focus talk: UNDERSTANDING ANTIDEPPRESSANT

04.30 - 05.00 VIDEO-PRESENTATION: ART MEETS SCIENCE. D Raytchev, D

DAY 2. Wednesday, January 17, 2018

09.00 – 09.30 Registration

09.30 – 10.10 ISBS Plenary Lecture 3: PAIN MANAGEMENT IN THE CANCER

10.10 - 01.15 SYMPOSIUM 2. LAPIN SYMPOSIUM ON TRANSLATIONAL BIO-

10.10 – 10.20 INTRODUCTION: PROFESSOR IZYASLAV LAPIN

10.20 - 10.40 ISBS Presidential Lecture 4: ZEBRAFISH MODELS OF DRUG ABUSE

11.20 - 11.35 PREVALENCE OF ORAL HPV INFECTION AMONG HEALTHY

11.35 – 11.50 Coffee Break

11.50 – 12.20 ISBS Plenary Lecture 6: UPDATE ON CANNABIS NEUROBIOLOGY. M

12.55 - 01.15 GENERAL DISCUSSION AND CONCLUDING REMARKS

DAY 3. Thursday, January 18, 2018

SOCIAL AND EDUCATIONAL TOURS

DAY 1. Tuesday, January 16, 2018

CONFERENCE OPENING REMARKS. BRIEF INTRODUCTION TO THE HISTORY OF ISBS

ISBS Lecture 1: PROTEIN KINASE C IN THE PATHOPHYSIOLOGY OF BIPOLAR ILLNESS:

INTRODUCTION: Lithium is a mood-stabilizing drug effective in the treatment of bipolar (BP)

ISBS Lecture 2: CELL-TYPE SPECIFIC MECHANISMS OF GENE-ENVIRONMENT

Multiple adverse environmental factors contribute to the pathogenesis of psychiatric disorders by

THE EFFECTS OF MINDFULNESS-ORIENTED RECOVERY ENHANCEMENT ON

INTRODUCTION: Chronic pain results in stress-induced neuroplastic changes to the extended

SYMPOSIUM 1. ZUKOWSKA SYMPOSIUM ON BIOLOGICAL PSYCHIATRY.

INTRODUCTION: PROFESSOR ZOFIA M ZUKOWSKA

Prof. ZOFIA M. ZUKOWSKA (1949-2012) received her M.D. and Ph.D.,

THE IMPACT OF A BEHAVIORAL INTERVENTION ON FAMILY CAREGIVERS’ C-REACTIVE

INTRODUCTION: Several decades of research have linked family caregiver distress to

DOES RUMINATION ALLOW TO PREDICT EMOTIONAL DISORDERS? M Dragan, University

INTRODUCTION: Rumination – a pattern of prolonged negative thinking – is associated with the

ISBS Special Focus talk: UNDERSTANDING ANTIDEPPRESSANT DISCONTINUATION

VIDEO-PRESENTATION: ART MEETS SCIENCE. D Raytchev, D Raytchev Art, London, UK

DAY 2. Wednesday, January 17, 2018

PAIN MANAGEMENT IN THE CANCER PATIENT. WCV Parris, Department of Anesthesiology,

SYMPOSIUM 2. LAPIN SYMPOSIUM ON TRANSLATIONAL BIOMEDICINE.

INTRODUCTION: PROFESSOR IZYASLAV P LAPIN

This regular ISBS symposium is dedicated to Professor Izyaslav ‘Slava’ P.

ISBS Presidential Lecture 4: ZEBRAFISH MODELS OF DRUG ABUSE AND STRESS. AV

PREVALENCE OF ORAL HPV INFECTION AMONG HEALTHY INDIVIDUALS AND HEAD

University Hospital of Martinique, Fort-de-France, Martinique, General Cancer Registry of

INTRODUCTION: Human papillomavirus (HPV) is known to play a role in the development of

ISBS Plenary Lecture 6: UPDATE ON CANNABIS NEUROBIOLOGY. M Fraites, St. Lucia, WI

ISBS Special Focus Lecture 7: STRESS INDUCED CHRONIC FATIGUE - REJUVENATING

GENERAL DISCUSSION AND CONCLUDING REMARKS

DAY 3. Thursday, January 18, 2018

SOCIAL AND EDUCATIONAL TOURS

THE INTERNATIONAL “STRESS